Hyped Science: Researchers Are Hurting Their Own Cause

Once upon a time, scientists assumed that a record of solid accomplishment was sufficient to maintain research support. They were not really interested in public visibility; on the contrary, they feared it would encourage outsiders to interfere in the research process. Even when research had obvious applications, scientists in most fields were careful to direct their initial findings toward their professional colleagues. Once supported by peer review, they then would go public through the pre

Written byDorothy Nelkin
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Once upon a time, scientists assumed that a record of solid accomplishment was sufficient to maintain research support. They were not really interested in public visibility; on the contrary, they feared it would encourage outsiders to interfere in the research process. Even when research had obvious applications, scientists in most fields were careful to direct their initial findings toward their professional colleagues. Once supported by peer review, they then would go public through the press. Major journals, such as Science and the New England Journal of Medicine have reinforced these norms by refusing to publish papers if their authors first report the findings to the media.

Things have changed. No better example exists than the recent claim by University of Utah scientists that they had triggered hydrogen fusion in a simple electrolytic cell, obtaining a substantial amount of energy. For decades, scientists have tried to achieve controlled hydrogen fusion. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies